vCJD epidemiology in France;Épidémiologie de la variante de la maladie de Creutzfeldt-Jakob en France

Transfusion Clinique et Biologique

Volumn 13, Issue 5, 2006, Pages 304-306

  Brandel, J P ^a   Salomon, D ^a   Alperovitch A ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

BSE; Incidence; Transfusion; vCJD

Indexed keywords

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; BOVINE SPONGIFORM ENCEPHALOPATHY; CLINICAL FEATURE; CREUTZFELDT JAKOB DISEASE; FRANCE; HUMAN; INCIDENCE; NEUROPATHOLOGY; RECIPIENT; SURVIVAL RATE; UNITED KINGDOM; BLOOD COMPONENT THERAPY; GENETIC VARIABILITY; GENETICS; TIME;

BLOOD COMPONENT TRANSFUSION; CREUTZFELDT-JAKOB SYNDROME; FRANCE; HUMANS; INCIDENCE; TIME FACTORS; VARIATION (GENETICS);

EID: 33846604986     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tracli.2006.11.002     Document Type: Article

References (14)

1. Will R.G., Ironside J.W., Zeidler M., et al. A new variant of CJD in the UK. Lancet 347 (1996) 921-925
2. Will R.G., Zeidler M., Stewart G.E., et al. Diagnosis of new variant of Creutzfeldt-Jakob disease. Ann. Neurol. 47 (2000) 575-582
3. Zeidler M., Sellar R.J., Collie D.A., et al. The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease. Lancet 355 (2000) 1412-1418
4. Zeidler M., Stewart G.E., Barraclough C.R., et al. New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests. Lancet 350 (1997) 903-907
5. Ironside J.W., Head M.W., Mc Cardle L., and Knight R. Neuropathology of variant Creutzfeldt-Jakob disease. Acta Neurobiol. Exp. (Warsz.) 62 (2002) 175-182
6. Chadeau-Hyam M., Tard A., Bird S., et al. Estimation of the exposure of the French population to the BSE agent: comparison of the 1980-1995 consumption of beef products containing mechanically recovered meat in France and the UK, by birth cohort and gender. Stat. Methods Med. Res. 12 (2003) 247-260
7. Alperovitch A., and Will R.G. Predicting the size of the vCJD epidemic in France. C. R. Biol. 325 (2002) 33-36
8. Cooper J.D., and Bird S.M. UK bovine carcass meat consumed as burgers, sausages and other meat products: by birth cohort and gender. J. Cancer Epidemiol. Prev. 7 (2002) 49-57
9. Chadeau-Hyam M., and Alperovitch A. Risk of variant Creutzfeldt-Jakob disease in France. Int. J. Epidemiol. 34 (2005) 46-52
10. Llewelyn C.A., Hewitt R.E., Knight R.S.E., et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363 (2004) 417-421
11. Hewitt P.E., Llewelyn C.A., Mackenzie J., and Will R.G. Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. Vox Sang. 91 (2006) 221-230
12. Peden A.H., Head M.W., Ritchie D.E., et al. Autopsy detection of pre-clinical vCJD transmission following blood transfusion from a PRNP codon 129 heterozygote. Lancet 364 (2004) 527-529
13. o°DGS/5C/DHOS/E2/2001/138 du 14 mars 2001 relative aux précautions à observer lors de soins en vue de réduire les risques de transmission d'agents transmissibles non conventionnels.
14. o°DGS/SD5C/DHOS/2005/435 du 23 septembre 2005 relative aux recommandations pour le traitement des dispositifs médicaux utilisés chez les sujets ayant reçu des produits sanguins labiles (PSL) provenant de donneurs rétrospectivement atteints de variant de la maladie de Creutzfeldt-Jakob (vMCJ).